
|Articles|January 6, 2005
Combination treatment increases survival in high-risk PCa patients
A combination of brachytherapy and external radiation plus androgen deprivation gives prostate cancer patients with high-risk disease a better chance of survival than patients treated with radiation alone, according to a study in the International Journal of Radiation Oncology*Biology*Physics (2005; 61:32-43).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












